首页> 外文期刊>Research in social & administrative pharmacy: RSAP >Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements
【24h】

Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements

机译:严重和可行的风险,以及披露:调查用于在处方药电视广告中呈现风险信息的替代方法

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundBroadcast direct-to-consumer (DTC) prescription drug ads that present product claims are required to also present the product's major risks. Debate exists regarding how much information should be included in these major risk statements. Some argue that such statements expose people to unnecessary amounts of information, while others argue that they leave out important information. ObjectivesExamine the impact of type of risk statement (unedited versus serious and actionable risks only) and a disclosure indicating that not all risks are presented on consumers' ability to remember the important risks and benefits of a drug following exposure to a DTC television advertisement (ad). Risk and benefit perceptions, ad-prompted actions, recognition of the disclosure statement, and evaluations of both the disclosure and risk statement were also examined. MethodsA web-based experiment was conducted in which US adults who self-reported as having depression (N?=?500), insomnia (N?=?500), or high cholesterol (N?=?500) were randomly assigned to view one of four versions of the television ad, and then complete a questionnaire. ResultsThe type of risk statement had a significant effect on risk recall and recognition, benefit recognition, perceived risk severity (depression condition only), and perceived benefit magnitude (high cholesterol condition only). Disclosure recognition (using bias-corrected scores) ranged from 63% to 70% across the three illness samples. ConclusionsThe revised risk statement improved overall processing of the television ad, as evidenced by improved risk recall and recognition and improved benefit recognition. Further, the presence of the disclosure did not adversely affect consumers' processing of drug risk and benefit information. Therefore, limiting the risks presented in DTC television ads and including a disclosure alerting consumers that not all risks are presented may be an effective strategy for communicating product risks.
机译:BackgroundBradcast直接到消费者(DTC)处方药广告目前的产品声明需要展示产品的主要风险。有关这些主要风险陈述中应列入多少信息的辩论存在辩论。有人认为,这些陈述使人们暴露于不必要的信息量,而其他人则认为他们遗漏了重要信息。客观的风险声明类型的影响(仅限UNEDITED与严重和可行的风险)和一份披露表明,并非所有风险都是为了消费者记住在暴露于DTC电视广告之后的药物的重要风险和益处(广告) )。还审查了风险和福利观念,宣传行动,承认披露声明以及对披露和风险陈述的评估。方法进行了基于Web的实验,其中美国成年人自报告为抑郁症(n?= 500),失眠(n?=Δ500)或高胆固醇(n?=?500)被随机分配到观看四个版本的电视广告之一,然后完成调查问卷。结果的风险声明类型对风险召回和识别,益处识别,感知风险严重程度(仅限抑郁状况)具有显着影响,并感知益处(仅限高胆固醇病症)。公开识别(使用偏置校正分数)在三种疾病样本中的63%至70%。结论经修订的风险声明改善了电视广告的整体处理,如改善风险回忆和认可和改善福利承认所证明。此外,本公开的存在对消费者的毒品风险和益处信息产生不利影响。因此,限制了DTC电视广告中提出的风险,包括披露警报消费者,并非所有风险都是沟通产品风险的有效策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号